[Skip to Content]
[Skip to Content Landing]
September 1970

Experimental Microembolization Of Cochlear Vessels

Author Affiliations

Oklahoma City
From the of Department of Otorhinolaryngology, University of Oklahoma Medical Center, Oklahoma City.

Arch Otolaryngol. 1970;92(3):213-220. doi:10.1001/archotol.1970.04310030003002

Microembolization of the cochlear vessels with a suspension of barium sulfate produces a decrease in the cochlear potential, eighth nerve action potential, and cochlear blood flow. One vasodilating agent, phenoxybenzamine hydrochloride (an αadrenergic blocking agent) appears to inhibit the deleterious effects of cochlear microembolization. The mechanism of this protection appears to be the prevention of reflex vasospasm in response to microembolization. Histopathologic examination of the temporal bones of the microembolized chronic animals reveals dilatation of the cochlear duct, degeneration of the organ of Corti and stria vascularis, and proliferation of fibrous and bony tissue into the cochlear lumen.